Engineering monoclonal antibodies to enhance drugability: A case study
This study demonstrates how DSC can be a useful tool in stability screening of engineered proteins
contributed by Malvern Panalytical |
In this application note, we compare stability data predicted by DSC of different engineered antibodies with SEC-HPLC data from accelerated stability studies. For the engineered proteins studied, there is a correlation between decreased thermostabilty based on DSC data, and greater aggregation formation during accelerated stability studies.
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!